23 results
424B5
NAMS
NewAmsterdam Pharma Company N.V.
9 Aug 24
Prospectus supplement for primary offering
5:21pm
price will be reduced as specified in the Warrant Assumption Agreement based on the Black-Scholes value (as defined in the Warrant Assumption
S-3
NAMS
NewAmsterdam Pharma Company N.V.
3 Jul 24
Shelf registration
4:31pm
disclosure of such transaction, the Warrant exercise price will be reduced as specified in the Warrant Assumption Agreement based on the Black-Scholes
DEF 14A
NAMS
NewAmsterdam Pharma Company N.V.
9 May 24
Definitive proxy
4:15pm
envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK
10-Q
2024 Q1
NAMS
NewAmsterdam Pharma Company N.V.
8 May 24
Quarterly report
4:30pm
inputs were available. The derivative earnout liability has been measured at fair value using a Black-Scholes pricing model. Given the assumed zero … value of the earnout liability resulting from the Black-Scholes pricing model is entirely driven by the Company’s closing share price as a Level 1 input
PRE 14A
xjvf 14gttfwjs60
29 Apr 24
Preliminary proxy
5:00pm
POS AM
bec3u8 pa0ka25irxxw4
12 Apr 24
Prospectus update (post-effective amendment)
4:15pm
424B3
9x8t5k5ccjg f514
12 Mar 24
Prospectus supplement
4:18pm
POS AM
iblck
28 Feb 24
Prospectus update (post-effective amendment)
5:01pm
10-K
19gcixncug a42tvhrx
28 Feb 24
Annual report
8:00am
10-K
EX-4.4
v2rgb84y0w4ry1i
28 Feb 24
Annual report
8:00am
424B5
wod4aia
15 Feb 24
Prospectus supplement for primary offering
4:15pm
424B5
zc8nutcvo
13 Feb 24
Prospectus supplement for primary offering
5:19pm
F-3
xsejuaj90wx59v8
7 Dec 23
Shelf registration (foreign)
4:16pm
424B3
lig4aikbkb4v6zxnov
15 Aug 23
Prospectus supplement
4:52pm
POS AM
duqt8
7 Aug 23
Prospectus update (post-effective amendment)
7:56am
6-K
EX-99.1
0mgz6 fbeie
7 Aug 23
Research and development expenses
7:24am
6-K
EX-99.3
888iemv 6h
5 Jun 23
Current report (foreign)
8:50am
424B3
ed4ifqe2bqq11d ec
25 Apr 23
Prospectus supplement
8:14am
POS AM
nld0bjfvtqd3tvum
17 Apr 23
Prospectus update (post-effective amendment)
9:09am